MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, PHAT had -$167,292K decrease in cash & cash equivalents over the period. -$167,004K in free cash flow.

Cash Flow Overview

Change in Cash
-$167,292K
Free Cash flow
-$167,004K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Accounts payable and accrued exp...
    • Stock-based compensation
    • Accrued interest on revenue inte...
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Accounts receivable, net
    • Inventory
    • Others

Cash Flow
2025-12-31
Net loss
-221,247
Depreciation and amortization
633
Stock-based compensation
28,719
Accrued payment-in-kind interest on debt
4,664
Accrued interest on revenue interest financing liability, net of payments
24,333
Amortization of debt discount
3,014
Inventory reserve
280
Other
-5,205
Prepaid expenses and other current assets
-5,513
Accounts receivable, net
39,331
Accounts payable and accrued expenses
34,104
Accrued interest
121
Operating right-of-use assets and lease liabilities
222
Inventory
11,781
Other long-term assets
1,224
Net cash used in operating activities
-166,775
Cash paid for property and equipment
229
Net cash used in investing activities
-229
Proceeds from issuance of common stock from exercise of stock options
1,638
Net proceeds from issuance of debt
0
Net proceeds from underwritten public offering
0
Payment of employee tax obligations related to vesting of psus and rsus
-1,926
Net cash (used in) provided by financing activities
-288
Net decrease in cash and cash equivalents and restricted cash
-167,292
Cash and cash equivalents and restricted cash - beginning of period
300,125
Cash and cash equivalents and restricted cash - end of period
132,833
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Net decrease in cashand cash...-$167,292K Accounts payable andaccrued expenses$34,104K Stock-based compensation$28,719K Accrued interest onrevenue interest...$24,333K Prepaid expenses andother current assets-$5,513K Other-$5,205K Accruedpayment-in-kind interest on debt$4,664K Amortization of debt discount$3,014K Depreciation andamortization$633K Inventory reserve$280K Operating right-of-useassets and lease...$222K Accrued interest$121K Proceeds from issuance ofcommon stock from...$1,638K Net cash used inoperating activities-$166,775K Net cash (used in)provided by financing...-$288K Net cash used ininvesting activities-$229K Canceled cashflow$106,808K Canceled cashflow$1,638K Net loss-$221,247K Payment of employee taxobligations related to...-$1,926K Cash paid forproperty and equipment$229K Accounts receivable, net$39,331K Inventory$11,781K Other long-termassets$1,224K

Phathom Pharmaceuticals, Inc. (PHAT)

Phathom Pharmaceuticals, Inc. (PHAT)